Effective Dates: 10/09/2024 - Present Previous | Next

DI 23022.000 Processing Quick Disability Determination (QDD) and Compassionate Allowances (CAL) in the Disability Determination Services (DDS)

Subchapter Table of Contents
Section   Latest
Transmittal
DI 23022.010 Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Fast-Track Processes TN 56 05-23
DI 23022.030 Identifying and Receipting Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Cases TN 24 02-19
DI 23022.040 Compassionate Allowances (CAL) and Quick Disability Determinations (QDD) Fast-Track Case Development TN 56 05-23
DI 23022.050 Making the Determination in Compassionate Allowances (CAL) or Quick Disability Determinations (QDD) Fast-Track Cases TN 18 11-18
DI 23022.055 Adding and Modifying Compassionate Allowances (CAL) Status; Removing and Reinstating CAL and Quick Disability Determinations (QDD) Status TN 71 07-24
DI 23022.060 Disability Determination Services Jurisdiction When a Compassionate Allowances or Quick Disability Determinations Claimant Moves to another State or Leaves the United States TN 24 02-19
DI 23022.075 Appeals Processing of Compassionate Allowances (CAL) Cases TN 24 02-19
DI 23022.080 List of Compassionate Allowances (CAL) Conditions TN 73 08-24
DI 23022.081 1p36 Deletion Syndrome TN 57 08-23
DI 23022.082 Adult Heart Transplant Wait List – Status Levels 1-4 TN 73 08-24
DI 23022.085 Acute Leukemia TN 35 08-20
DI 23022.090 Adrenal Cancer with Distant Metastases or Inoperable, Unresectable or Recurrent TN 60 10-23
DI 23022.095 Alexander Disease - Child TN 54 09-22
DI 23022.100 Amyotrophic Lateral Sclerosis (ALS) - ADULT TN 69 12-23
DI 23022.105 Anaplastic Adrenal Cancer - Adult with Distant Metastases or Inoperable, Unresectable or Recurrent TN 61 10-23
DI 23022.106 Angiosarcoma TN 54 09-22
DI 23022.110 Astrocytoma - Grade III and IV TN 54 09-22
DI 23022.111 Atypical Teratoid/Rhabdoid Tumor TN 54 09-22
DI 23022.112 Bainbridge-Ropers Syndrome TN 73 08-24
DI 23022.115 Bladder Cancer with Distant Metastases or Inoperable or Unresectable TN 61 10-23
DI 23022.117 Blastic Plasmacytoid Dendritic Cell Neoplasm TN 53 08-22
DI 23022.120 Osteosarcoma, formerly known as Bone Cancer TN 60 10-23
DI 23022.125 Breast Cancer – with Distant Metastases or Recurrent TN 61 10-23
DI 23022.127 CACH - Vanishing White Matter Disease - Congenital, Infantile, and Early Childhood Onset Forms TN 34 08-20
DI 23022.128 Calciphylaxis TN 57 08-23
DI 23022.130 Canavan Disease TN 54 09-22
DI 23022.133 CDKL5 Deficiency Disorder TN 54 09-22
DI 23022.135 Cerebro Oculo Facio Skeletal (COFS) Syndrome TN 35 08-20
DI 23022.136 Chronic Idiopathic Intestinal Pseudo Obstruction TN 54 09-22
DI 23022.140 Chronic Myelogenous Leukemia (CML) - Blast Phase TN 35 08-20
DI 23022.141 Coffin-Lowry Syndrome TN 34 08-20
DI 23022.143 Congenital Myotonic Dystrophy TN 56 05-23
DI 23022.144 Charlevoix-Saguenay Spastic Ataxia TN 54 09-22
DI 23022.145 Creutzfeldt-Jakob Disease (CJD) TN 54 09-22
DI 23022.146 Desmoplastic Small Round Cell Tumors TN 37 09-20
DI 23022.150 Ependymoblastoma (Child Brain Cancer) TN 54 09-22
DI 23022.155 Esophageal Cancer TN 54 09-22
DI 23022.156 Esthesioneuroblastoma TN 35 08-20
DI 23022.160 Farber's Disease TN 34 08-20
DI 23022.163 Fibrolamellar Cancer TN 54 09-22
DI 23022.165 Friedreich's Ataxia (FRDA) TN 34 08-20
DI 23022.170 Frontotemporal Dementia (FTD), Pick's Disease - Type A - Adult TN 69 12-23
DI 23022.175 Gallbladder Cancer TN 35 08-20
DI 23022.180 Gaucher Disease (GD) - Type 2 TN 54 09-22
DI 23022.181 Giant Axonal Neuropathy TN 34 08-20
DI 23022.185 Glioblastoma Multiforme (Adult Brain Cancer) TN 61 10-23
DI 23022.186 GM1 - Gangliosidosis - Infantile & Juvenile Forms TN 54 09-22
DI 23022.190 Head and Neck Cancers - with Distant Metastasis or Inoperable or Unresectable TN 61 10-23
DI 23022.191 Hoyeraal-Hreidarsson Syndrome TN 34 08-20
DI 23022.195 Infantile Neuroaxonal Dystrophy (INAD) TN 34 08-20
DI 23022.200 Inflammatory Breast Cancer TN 35 08-20
DI 23022.201 Intracranial Hemangiopericytoma TN 35 08-20
DI 23022.202 Joubert Syndrome TN 34 08-20
DI 23022.205 Kidney Cancer - Inoperable or Unresectable TN 61 10-23
DI 23022.207 Kleefstra Syndrome TN 34 08-20
DI 23022.210 Krabbe Disease (KD) - Infantile TN 34 08-20
DI 23022.215 Large Intestine Cancer - with Distant Metastasis or Inoperable, Unresectable or Recurrent TN 61 10-23
DI 23022.216 Leptomeningeal Carcinomatosis TN 54 09-22
DI 23022.220 Lesch-Nyhan Syndrome (LNS) TN 56 05-23
DI 23022.221 Liposarcoma - Metastatic or Recurrent TN 54 09-22
DI 23022.225 Hepatocellular Carcinoma TN 54 09-22
DI 23022.226 Malignant Ectomesenchymoma TN 54 09-22
DI 23022.227 Malignant Renal Rhabdoid Tumor TN 35 08-20
DI 23022.230 Mantle Cell Lymphoma (MCL) TN 52 06-22
DI 23022.231 Marshall-Smith Syndrome TN 35 08-20
DI 23022.233 Megacystis Microcolon Intestinal Hypoperistalsis Syndrome TN 35 08-20
DI 23022.234 Megalencephaly-Capillary Malformation Syndrome TN 35 08-20
DI 23022.235 Metachromatic Leukodystrophy (MLD) - Late Infantile TN 69 12-23
DI 23022.236 Nicolaides-Baraitser Syndrome TN 28 08-20
DI 23022.238 SYNGAP1-related NSID TN 45 08-21
DI 23022.240 Niemann-Pick Disease (NPD) - Type A TN 35 08-20
DI 23022.245 Non-Small Cell Lung Cancer TN 35 08-20
DI 23022.246 Oligodendroglioma Brain Cancer - Grade III TN 54 09-22
DI 23022.250 Ornithine Transcarbamylase (OTC) Deficiency TN 54 09-22
DI 23022.255 Osteogenesis Imperfecta (OI) - Type II TN 35 08-20
DI 23022.260 Ovarian Cancer - with Distant Metastases or Inoperable or Unresectable TN 60 10-23
DI 23022.261 Pallister-Killian Syndrome TN 34 08-20
DI 23022.265 Pancreatic Cancer TN 33 08-20
DI 23022.266 Pericardial Mesothelioma TN 45 08-21
DI 23022.270 Peritoneal Mesothelioma TN 54 09-22
DI 23022.273 Pineoblastoma – Childhood TN 57 08-23
DI 23022.274 Plasmablastic Lymphoma TN 73 08-24
DI 23022.275 Pleural Mesothelioma TN 33 08-20
DI 23022.280 Pompe Disease - Infantile TN 34 08-20
DI 23022.281 Progressive Bulbar Palsy TN 34 08-20
DI 23022.282 Prostate Cancer – Hormone Refractory Disease – or with Visceral Metastases TN 60 10-23
DI 23022.283 Refractory Hodgkin Lymphoma TN 45 08-21
DI 23022.284 Renpenning Syndrome TN 54 09-22
DI 23022.285 Rett Syndrome (RTT) TN 34 08-20
DI 23022.286 Revesz Syndrome TN 54 09-22
DI 23022.287 Rubinstein-Taybi Syndrome TN 28 08-20
DI 23022.290 Salivary Cancers TN 33 08-20
DI 23022.295 Sandhoff Disease TN 33 08-20
DI 23022.296 Seckel Syndrome TN 34 08-20
DI 23022.297 Sjögren-Larsson Syndrome TN 64 10-23
DI 23022.298 Secondary Adenocarcinoma of the Brain TN 40 10-20
DI 23022.300 Small Cell Cancer of the Large Intestine TN 54 09-22
DI 23022.305 Small Cell Cancer of the Ovary TN 36 09-20
DI 23022.310 Small Cell Cancer of the Prostate TN 36 09-20
DI 23022.311 Small Cell Cancer of the Thymus TN 36 09-20
DI 23022.315 Small-Cell Cancer of the Female Genital Tract TN 60 10-23
DI 23022.320 Small Cell Lung Cancer TN 36 09-20
DI 23022.325 Small Intestine Cancer - with Distant Metastases or Inoperable or Recurrent TN 60 10-23
DI 23022.326 Soft Tissue Sarcoma - with Distant Metastases or Recurrent TN 60 10-23
DI 23022.330 Spinal Muscular Atrophy (SMA) - Types 0 and 1 TN 40 10-20
DI 23022.335 Stomach Cancer, with Distant Metastases or Inoperable, Unresectable or Recurrent TN 60 10-23
DI 23022.337 Superficial Siderosis of the Central Nervous System TN 36 09-20
DI 23022.340 Anaplastic Thyroid Cancer TN 60 10-23
DI 23022.341 Taybi-Linder Syndrome TN 47 08-21
DI 23022.343 Tetrasomy 18p TN 36 09-20
DI 23022.344 Trisomy 9 TN 57 08-23
DI 23022.345 Ureter Cancer - with Metastases or Inoperable, Unresectable or Recurrent TN 60 10-23
DI 23022.346 X-Linked Lymphoproliferative Disease TN 36 09-20
DI 23022.347 X-Linked Myotubular Myopathy TN 49 10-21
DI 23022.350 Alstrom Syndrome TN 31 08-20
DI 23022.355 Amegakaryocytic Thrombocytopenia TN 56 05-23
DI 23022.357 Angioimmunoblastic T-Cell Lymphoma TN 53 08-22
DI 23022.360 Ataxia Telangiectasia TN 38 09-20
DI 23022.365 Batten Disease TN 40 10-20
DI 23022.370 Bilateral Retinoblastoma TN 31 08-20
DI 23022.373 Congenital Zika Syndrome TN 47 08-21
DI 23022.374 Costello Syndrome TN 73 08-24
DI 23022.375 Cri du Chat Syndrome TN 40 10-20
DI 23022.380 Degos Disease - Systemic TN 31 08-20
DI 23022.382 Desmoplastic Mesothelioma TN 45 08-21
DI 23022.385 Early-Onset Alzheimer's Disease TN 38 09-20
DI 23022.390 Edwards Syndrome (Trisomy 18) TN 69 12-23
DI 23022.395 Fibrodysplasia Ossificans Progressiva TN 49 10-21
DI 23022.400 Fukuyama Congenital Muscular Dystrophy TN 40 10-20
DI 23022.403 Gerstmann-Straussler-Scheinker Disease TN 53 08-22
DI 23022.405 Hemophagocytic Lymphohistiocytosis - Familial Type (FHLH) TN 66 11-23
DI 23022.407 Histiocytic Malignancies TN 73 08-24
DI 23022.410 MPS II TN 69 12-23
DI 23022.415 MPS I TN 69 12-23
DI 23022.420 Idiopathic Pulmonary Fibrosis TN 35 08-20
DI 23022.425 Infantile Neuronal Ceroid Lipofuscinoses TN 68 12-23
DI 23022.430 Junctional Epidermolysis Bullosa - Lethal Type TN 68 12-23
DI 23022.435 Late Infantile Neuronal Ceroid Lipofuscinoses TN 68 12-23
DI 23022.437 Leber Congenital Amaurosis TN 57 08-23
DI 23022.440 Leigh's Disease TN 35 08-20
DI 23022.445 Maple Syrup Urine Disease TN 38 09-20
DI 23022.450 Merosin Deficient Congenital Muscular Dystrophy TN 40 10-20
DI 23022.453 Microvillus Inclusion Disease – Child TN 53 08-22
DI 23022.455 Mixed Dementias TN 38 09-20
DI 23022.457 Mowat-Wilson Syndrome TN 53 08-22
DI 23022.460 Mucosal Malignant Melanoma TN 32 08-20
DI 23022.463 Myelodysplastic Syndrome with Excess Blasts TN 53 08-22
DI 23022.465 Neonatal Adrenoleukodystrophy TN 32 08-20
DI 23022.468 Neonatal Marfan Syndrome TN 73 08-24
DI 23022.470 Glutaric Acidemia - Type II TN 61 10-23
DI 23022.475 Niemann-Pick Disease - Type C TN 32 08-20
DI 23022.477 NUT Carcinoma TN 53 08-22
DI 23022.480 Patau Syndrome (Trisomy 13) TN 33 08-20
DI 23022.481 Pfeiffer Syndrome - Types II and III TN 53 08-22
DI 23022.482 Pontocerebellar Hypoplasia TN 53 08-22
DI 23022.483 Primary Peritoneal Cancer TN 33 08-20
DI 23022.485 Primary Progressive Aphasia TN 54 09-22
DI 23022.490 Progressive Multifocal Leukoencephalopathy TN 40 10-20
DI 23022.495 MPS III TN 69 12-23
DI 23022.496 SCN8A-related Epilepsy with Encephalopathy TN 45 08-21
DI 23022.500 Spinocerebellar Ataxia TN 36 09-20
DI 23022.503 Snijders Blok-Campeau Syndrome TN 73 08-24
DI 23022.505 Subacute Sclerosing Panencephalitis TN 54 09-22
DI 23022.510 Tay Sachs Disease, Infantile Type TN 36 09-20
DI 23022.515 Thanatophoric Dysplasia, Type 1 TN 36 09-20
DI 23022.520 Ullrich Congenital Muscular Dystrophy TN 38 09-20
DI 23022.525 Walker Warburg Syndrome TN 36 09-20
DI 23022.530 Wolman Disease TN 36 09-20
DI 23022.535 Zellweger Syndrome TN 36 09-20
DI 23022.536 Anaplastic Ependymoma TN 57 08-23
DI 23022.540 Aortic Atresia TN 31 08-20
DI 23022.543 CIC-rearranged Sarcoma TN 47 08-21
DI 23022.545 Eisenmenger Syndrome TN 31 08-20
DI 23022.550 Endomyocardial Fibrosis TN 31 08-20
DI 23022.555 Heart Transplant Graft Failure TN 32 08-20
DI 23022.560 Child Heart Transplant Wait List - Status Levels 1A/1B TN 73 08-24
DI 23022.565 Hypoplastic Left Heart Syndrome TN 32 08-20
DI 23022.570 Ventricular Assist Device Recipient — Left, Right, or Biventricular TN 36 09-20
DI 23022.575 Mitral Valve Atresia TN 32 08-20
DI 23022.580 Cardiac Amyloidosis - AL Type TN 31 08-20
DI 23022.585 Pulmonary Atresia TN 33 08-20
DI 23022.586 Sarcomatoid Carcinoma of the Lung—Stages II-IV TN 57 08-23
DI 23022.587 Sarcomatoid Mesothelioma TN 53 08-22
DI 23022.590 Single Ventricle TN 33 08-20
DI 23022.595 Tricuspid Atresia TN 36 09-20
DI 23022.600 Angelman Syndrome TN 38 09-20
DI 23022.605 Corticobasal Degeneration TN 38 09-20
DI 23022.610 Lewy Body Dementia TN 72 08-24
DI 23022.615 Lowe Syndrome TN 35 08-20
DI 23022.620 Malignant Multiple Sclerosis TN 38 09-20
DI 23022.625 Multicentric Castleman Disease TN 38 09-20
DI 23022.630 Multiple System Atrophy TN 39 10-20
DI 23022.633 Paraneoplastic Cerebellar Degeneration TN 57 08-23
DI 23022.635 Paraneoplastic Pemphigus TN 62 10-23
DI 23022.640 Primary Central Nervous System Lymphoma TN 33 08-20
DI 23022.643 Posterior Cortical Atrophy TN 53 08-22
DI 23022.645 Primary Effusion Lymphoma TN 33 08-20
DI 23022.647 Primary Omental Cancer TN 57 08-23
DI 23022.650 Progressive Supranuclear Palsy TN 33 08-20
DI 23022.655 Pulmonary Kaposi Sarcoma TN 54 09-22
DI 23022.660 ALS/Parkinsonism Dementia Complex TN 69 12-23
DI 23022.665 Aicardi--Goutieres Syndrome TN 30 08-20
DI 23022.670 Alobar Holoprosencephaly TN 43 10-20
DI 23022.675 Alpers Disease TN 30 08-20
DI 23022.680 Alpha Mannosidosis--Types II and III TN 69 12-23
DI 23022.685 Carcinoma of Unknown Primary Site TN 35 08-20
DI 23022.690 Cerebrotendinous Xanthomatosis TN 30 08-20
DI 23022.695 Child Neuroblastoma—with distant metastases or recurrent TN 35 08-20
DI 23022.700 Child Lymphoma TN 35 08-20
DI 23022.704 Cholangiocarcinoma TN 57 08-23
DI 23022.705 Chondrosarcoma—with multimodal therapy TN 35 08-20
DI 23022.710 Cornelia de Lange Syndrome--Classic Form TN 35 08-20
DI 23022.715 Ewing Sarcoma TN 35 08-20
DI 23022.720 Follicular Dendritic Cell Sarcoma -- metastatic or recurrent TN 35 08-20
DI 23022.723 FOXG1 Syndrome TN 57 08-23
DI 23022.725 Fucosidosis -- Type I TN 35 08-20
DI 23022.730 Galactosialidosis -- Early and Late Infantile Types TN 35 08-20
DI 23022.735 Glioma - Grade III and IV TN 35 08-20
DI 23022.745 Hepatoblastoma TN 32 08-20
DI 23022.750 Histiocytosis Syndromes TN 73 08-24
DI 23022.755 Hutchinson-Gilford Progeria Syndrome TN 32 08-20
DI 23022.760 Hydranencephaly TN 32 08-20
DI 23022.765 Hypocomplementemic Urticarial Vasculitis Syndrome TN 43 10-20
DI 23022.770 Hypophosphatasia--Perinatal (Lethal) and Infantile Onset Types TN 32 08-20
DI 23022.775 I Cell Disease TN 32 08-20
DI 23022.780 Infantile Free Sialic Acid Storage Disease TN 32 08-20
DI 23022.785 Juvenile Onset Huntington Disease TN 30 08-20
DI 23022.790 Kufs Disease -- Type A and B TN 68 12-23
DI 23022.795 Lissencephaly TN 30 08-20
DI 23022.800 Lymphomatoid Granulomatosis -- Grade III TN 32 08-20
DI 23022.805 Malignant Brainstem Gliomas -- Childhood TN 32 08-20
DI 23022.810 Skin Malignant Melanoma with Metastases TN 60 10-23
DI 23022.815 Mastocytosis Type IV TN 32 08-20
DI 23022.820 Child Medulloblastoma TN 70 01-24
DI 23022.825 Merkel Cell Carcinoma – with metastases TN 32 08-20
DI 23022.827 Metastatic Endometrial Adenocarcinoma TN 57 08-23
DI 23022.830 Myoclonic Epilepsy with Ragged Red Fibers Syndrome TN 41 10-20
DI 23022.835 Nephrogenic Systemic Fibrosis TN 62 10-23
DI 23022.836 Neurodegeneration with Brain Iron Accumulation - Types 1 and 2 TN 69 12-23
DI 23022.840 Obliterative Bronchiolitis TN 32 08-20
DI 23022.845 Ohtahara Syndrome TN 30 08-20
DI 23022.850 Orthochromatic Leukodystrophy with Pigmented Glia TN 44 11-20
DI 23022.853 PACS1 Syndrome TN 73 08-24
DI 23022.855 Pearson Syndrome TN 33 08-20
DI 23022.860 Pelizaeus-Merzbacher Disease--Classic Form TN 54 09-22
DI 23022.865 Pelizaeus-Merzbacher Disease--Connatal Form TN 30 08-20
DI 23022.870 Peripheral Nerve Cancer – Metastatic or Recurrent TN 60 10-23
DI 23022.875 Perry Syndrome TN 30 08-20
DI 23022.877 Pitt Hopkins Syndrome TN 33 08-20
DI 23022.878 Renal Amyloidosis – AL Type TN 53 08-22
DI 23022.879 Renal Medullary Carcinoma TN 73 08-24
DI 23022.880 Rhabdomyosarcoma TN 33 08-20
DI 23022.885 Rhizomelic Chondrodysplasia Punctata TN 33 08-20
DI 23022.887 Richter Syndrome TN 54 09-22
DI 23022.890 Schindler Disease -- Type I TN 69 12-23
DI 23022.895 Smith Lemli Opitz Syndrome TN 36 09-20
DI 23022.900 Spinal Nerve Root Cancer – Metastatic or Recurrent TN 60 10-23
DI 23022.905 Stiff Person Syndrome TN 30 08-20
DI 23022.910 Tabes Dorsalis TN 30 08-20
DI 23022.915 Wolf-Hirschhorn Syndrome TN 36 09-20
DI 23022.920 Xeroderma Pigmentosum TN 62 10-23
DI 23022.921 Adult Non-Hodgkin Lymphoma TN 31 08-20
DI 23022.923 Adult Onset Huntington Disease TN 54 09-22
DI 23022.925 Allan-Herndon-Dudley Syndrome TN 30 08-20
DI 23022.927 Alveolar Soft Part Sarcoma TN 31 08-20
DI 23022.929 Aplastic Anemia TN 31 08-20
DI 23022.931 Beta Thalassemia Major TN 31 08-20
DI 23022.933 Bilateral Optic Atrophy - Infantile TN 31 08-20
DI 23022.935 Caudal Regression Syndrome - Types III and IV TN 30 08-20
DI 23022.937 Child Lymphoblastic Lymphoma TN 41 10-20
DI 23022.938 Choroid Plexus Carcinoma TN 45 08-21
DI 23022.939 Congenital Lymphedema TN 62 10-23
DI 23022.940 Duchenne Muscular Dystrophy - Adult TN 46 08-21
DI 23022.941 De Sanctis Cacchione Syndrome TN 62 10-23
DI 23022.943 Dravet Syndrome TN 31 08-20
DI 23022.945 Endometrial Stromal Sarcoma TN 31 08-20
DI 23022.947 Erdheim Chester Disease TN 41 10-20
DI 23022.949 Fatal Familial Insomnia TN 30 08-20
DI 23022.951 Fryns Syndrome TN 31 08-20
DI 23022.953 Fulminant Giant Cell Myocarditis TN 31 08-20
DI 23022.955 Hepatopulmonary Syndrome TN 32 08-20
DI 23022.957 Hepatorenal Syndrome TN 32 08-20
DI 23022.959 Jervell and Lange-Nielsen Syndrome TN 32 08-20
DI 23022.961 Leiomyosarcoma TN 32 08-20
DI 23022.963 Malignant Gastrointestinal Stromal Tumor TN 32 08-20
DI 23022.965 Malignant Germ Cell Tumor TN 32 08-20
DI 23022.967 MECP2 Duplication Syndrome TN 30 08-20
DI 23022.969 Menkes Disease - Classic or Infantile Onset Form TN 32 08-20
DI 23022.971 NFU-1 Mitochondrial Disease TN 32 08-20
DI 23022.973 Nonketotic Hyperglycinemia TN 30 08-20
DI 23022.975 Peritoneal Mucinous Carcinomatosis TN 33 08-20
DI 23022.977 Phelan-McDermid Syndrome TN 54 09-22
DI 23022.979 Retinopathy of Prematurity - Stage V, Bilateral TN 33 08-20
DI 23022.981 Roberts Syndrome TN 49 10-21
DI 23022.983 Severe Combined Immunodeficiency -- Childhood TN 33 08-20
DI 23022.985 Sinonasal Cancer TN 33 08-20
DI 23022.987 Transplant Coronary Artery Vasculopathy TN 36 09-20
DI 23022.989 Usher Syndrome - Type I TN 36 09-20
To Link to this section - Use this URL:
http://policy.ssa.gov/poms.nsf/lnx/0423022000
DI 23022.000 - Processing Quick Disability Determination (QDD) and Compassionate Allowances (CAL) in the Disability Determination Services (DDS) - Table of Contents - 10/09/2024
Batch run: 10/09/2024
Rev:10/09/2024